Related Experiment Video

Updated: Mar 26, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

13.3K

An improved method for detection of pyrazinamide resistance in Mycobacterium tuberculosis

Amani Alnimr1, Timothy D McHugh2, Stephen H Gillespie3

  • 1Department of Medical Microbiology, College of Medicine, University of Dammam, P.O. BOX 2114, Dammam 31451, Saudi Arabia.

International Journal of Mycobacteriology
|January 21, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format
12:39

Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format

Published on: June 24, 2011

39.0K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

82.3K

Related Experiment Videos

Last Updated: Mar 26, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

13.3K
Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format
12:39

Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format

Published on: June 24, 2011

39.0K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

82.3K

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

768
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
768
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

632
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
632

Articles linked to this work by shared authors, journal, and citation graph.

Country-level heterogeneity in MDR-TB drug susceptibility supports country-specific policy development.

Frontiers in tuberculosis·2026

Analyses of blood-derived host biomarkers for pulmonary tuberculosis diagnosis in human immunodeficiency virus co-infected individuals in sub-Saharan Africa: a systematic review and meta-analysis.

Frontiers in tuberculosis·2026

Bioinspired peptide cyclisation enables exploration of cytochrome P450 catalysed sequential oxidation in rufomycin biosynthesis.

Chemical science·2026

Advances in tuberculosis treatment: novel regimens, new drug pipelines, host-directed therapies, and updated management guidelines.

The Lancet. Microbe·2026

Advances in tuberculosis diagnostics and biomarkers, 2020-26: scientific evidence, recommendations, gaps, and developmental priorities.

The Lancet. Microbe·2026

Forensic postmortem examination as sentinel evidence of rifampicin-resistant tuberculosis outside routine clinical reporting.

IJID regions·2026

Concurrent Multibacillary Lepromatous Leprosy with Autonomic Dysfunction and Cavitary Pulmonary Tuberculosis Complicated by Spontaneous Pneumothorax and Subcutaneous Emphysema.

International journal of mycobacteriology·2026

Pulmonary Tuberculosis following Chemotherapy for Metastatic Testicular Germ Cell Tumor: Possible Reactivation of Latent Tuberculosis Infection.

International journal of mycobacteriology·2026

Disseminated Mycobacterium immunogenum -associated Hemophagocytic Lymphohistiocytosis after Stem Cell Transplantation.

International journal of mycobacteriology·2026

Recurrent Paradoxical Reactions in Cervical Tuberculous Lymphadenitis During and after Antitubercular Therapy in an Immunocompetent Patient.

International journal of mycobacteriology·2026

A Rare Infection in a Patient with Systemic Lupus Erythematosus Treated with Mycophenolate Mofetil.

International journal of mycobacteriology·2026

Performance of Molecular Diagnostics in Strengthening Tuberculosis Detection and Drug Resistance Surveillance: A Comparative Study with Conventional Methods.

International journal of mycobacteriology·2026

Efficacy of Bromhexine hydrochloride combined with bronchoalveolar lavage under fiberoptic bronchoscopy in the treatment of mild to moderate community-acquired pneumonia.

Pakistan journal of medical sciences·2026

Multidrug resistant bacterial infection in liver transplant recipients: A Deterrent and obstacle.

Pakistan journal of medical sciences·2026

Tannic acid attenuates Pseudomonas aeruginosa virulence and promotes healing of infected cutaneous wounds: phenotypic and transcriptomic analyses.

Microbial pathogenesis·2026

Radiological Patterns of Abdominal Tuberculosis With Microbiological Confirmation: A Multi-Modal Prospective Analysis.

Cureus·2026

Characteristics of Primary and acquired multidrug-resistant tuberculosis patients in West Java, Indonesia.

IJID regions·2026

Finerenone Alleviates Cardiac Microvascular Injury and Neutrophil Extracellular Traps Formation in Diabetic Cardiomyopathy via Regulating AKT1 Phosphorylation.

Acta physiologica (Oxford, England)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us